Clinic Rochester, Rochester, MN. RATIONALE: Environmental exposure to allergens plays critical roles in development of allergic diseases. The goal of this project was to investigate the immunologic mechanisms involved in the development of peanut allergy by using mouse models of exposure to natural peanut allergens through skin or airways. METHODS: For skin sensitization, na€ ıve BALB/c mice were painted with peanut flour twice a week for 4 weeks. Alternatively, mice were intranasally exposed to peanut flour. No exogenous adjuvants were used. Immunological mechanisms were investigated by using a series of genetic models. RESULTS: When exposed through skin or airways, na€ ıve mice developed peanut allergy as demonstrated by increased serum levels of peanutspecific IgE and IgG antibodies and by manifestation of acute anaphylaxis symptoms. Mice deficient in follicular helper T (Tfh) cells were protected from developing peanut allergy in either skin or airway sensitization. Several major differences were observed, however. In wild type mice, airway sensitization produced ;100x higher titers of peanut-specific IgG1, IgG2a, and IgG2b antibodies while IgE antibody titers were roughly comparable. In IL-4Ra-deficient mice, IgE antibody was abolished in skin sensitization while IgE was partially inhibited and IgG antibodies increased in airway sensitization. Anaphylactic responses were dependent on IgE and the IL-4Ra pathway in skin sensitization while it was independent of them in airway sensitization. CONCLUSIONS: Irrespective of whether animals are exposed through skin or airways, Tfh cells play a critical role in development of peanut allergy. While skin sensitization promotes IL-4-and IgE-dependent peanut allergy, airway sensitization promotes the response(s) independent of these molecules.
Peanut Allergy is Induced by Distinct Immunologic Pathways Dependent on the Routes of Allergen Exposure in Mice
Koji Iijima, Ph.D., Takao Kobayashi, Ph.D., Takayasu Nomura, M.D., Rinna Tei, M.D., James Krempski, B.S., and Hirohito Kita, MD; Mayo Clinic Rochester, Rochester, MN. RATIONALE: Environmental exposure to allergens plays critical roles in development of allergic diseases. The goal of this project was to investigate the immunologic mechanisms involved in the development of peanut allergy by using mouse models of exposure to natural peanut allergens through skin or airways. METHODS: For skin sensitization, na€ ıve BALB/c mice were painted with peanut flour twice a week for 4 weeks. Alternatively, mice were intranasally exposed to peanut flour. No exogenous adjuvants were used. Immunological mechanisms were investigated by using a series of genetic models. RESULTS: When exposed through skin or airways, na€ ıve mice developed peanut allergy as demonstrated by increased serum levels of peanutspecific IgE and IgG antibodies and by manifestation of acute anaphylaxis symptoms. Mice deficient in follicular helper T (Tfh) cells were protected from developing peanut allergy in either skin or airway sensitization. Several major differences were observed, however. In wild type mice, airway sensitization produced ;100x higher titers of peanut-specific IgG1, IgG2a, and IgG2b antibodies while IgE antibody titers were roughly comparable. In IL-4Ra-deficient mice, IgE antibody was abolished in skin sensitization while IgE was partially inhibited and IgG antibodies increased in airway sensitization. Anaphylactic responses were dependent on IgE and the IL-4Ra pathway in skin sensitization while it was independent of them in airway sensitization. CONCLUSIONS: Irrespective of whether animals are exposed through skin or airways, Tfh cells play a critical role in development of peanut allergy. While skin sensitization promotes IL-4-and IgE-dependent peanut allergy, airway sensitization promotes the response(s) independent of these molecules.
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Immune Food Allergy Center, Massachusetts General Hospital, Boston, MA. RATIONALE: Individuals with peanut allergy range in clinical sensitivity from those who can consume grams of peanut without any symptoms to those who have multi-system reactions to as little as ;1 mg. This clinical heterogeneity makes informed decisions about who to treat dependent upon better understanding its immunological underpinnings. METHODS: We compared the TCRb usage and phenotypes of peanutactivated, CD154 + CD4 + memory T cells in 20 peanut-allergic patients classified as either reactive (10) or hyporeactive (10) based upon a blinded graded peanut protein ingestion challenge with a cumulative dose of 443 mg. RESULTS: TCRb analysis of the CD154 + and CD154 -fractions to identify significantly enriched sequences revealed >1000 public CDR3s as well as enriched CDR3 amino acid motifs, consistent with the strong selection of peanut-specific clones. These putatively-specific clones were expanded in frequency and diversity among the reactive patients and this expansion occurred within effector, but not regulatory T cell populations. The ratio of putatively peanut-specific effector T cells to regulatory T cells was 1.5-fold higher in reactive than in hyporeactive patients (p<0.01). Transcriptional analysis of peanut-activated T cells revealed an association between clinical reactivity and a gene set associated with strongly polarized Th2 effector cells, including IL-5, IL-9, and HPGDS (p<0.05). Increased expression of Th2 cytokines was confirmed at the protein level, and strongly correlated with peanut-specific IgE. CONCLUSIONS: Immune progression within the effector T cell compartment is correlated to clinical sensitivity, and this observation may be useful to inform our assessment of disease phenotype and to monitor disease longitudinally.
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Identification of An Antigenic Region Involved In IgE Cross-reactivity Between Fatty Acid Binding Proteins (FABP) from Shrimp and Human Marlon Munera, MSc., Dalgys Mart ınez, MSc., Luis Caraballo, MD PhD, and Leonardo Puerta, PhD; Institute for Immunological Research, University of Cartagena, Cartagena, Colombia. RATIONALE: FABP from shrimp Litopenaeus vannamei (LvFABP) and the human (Heart-FABP and Adipocyte-FABP) are functional and structural homologous proteins. This could allow that antibodies from an immune response to shrimp cross-react against the human FABP. METHODS: Fifty-six sera from individuals sensitized to L. vannamei extract were selected for analysis of IgE and IgG reactivity to LvFABP, H-FABP and A-FABP. Overlapping peptides from LvFABP and human sera were used to map B cell epitopes. Cross-reactivity was explored by ELISA inhibition assays, using pool of sensitized sera, the recombinant FABPs and also the peptide sharing 65% of amino acid identity among these FABPs. In addition, modelling by homology was apply to localize cross-reactive regions. RESULTS: IgE reactivity to LvFABP, H-FABP and A-FABP was found in eleven sera. IgE cross-reactivity was 52% between LvFABP and H-FABP and 48% between LvFABP and A-FABP. IgG cross-reactivity was 60% between LvFABP and AFABP and 48% between LvFABP and H-FABP. The LvFABP peptide with higher amino identity with human FABP (amino acid residues 58 to 74) showed 55% IgE cross-reactivity with these FABPs. Modelling by homology revealed a high structural homology in the regions occupied by the cross-reactive peptide, which is located in A, B and C b strands on the barrel structure of the analyzed FABPs. CONCLUSIONS: We identified an antigenic region involved in crossreactivity between shrimp and human FABP, which suggest that LvFABP could induce, by molecular mimicry, an antibody response to homologous human FABP.
